IP Library Granted Patent US 7,842,726
Granted Patent B2
US 7,842,726 · App. 12/088,792 · Granted Nov 30, 2010

Carnitine derivative, salt thereof, external skin preparation and cosmetic material

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,842,726
App. No.
12/088,792
Granted
Nov 30, 2010
Kind
B2
Abstract

To provide novel carnitine derivatives and salts thereof that are resistant to hydrolysis in the presence of aqueous media, and also provide external skin preparations and cosmetics that are excellent in storage stability, product life, skin affinity and percutaneous absorption properties. In particular, to provide novel α-branched acyl carnitine derivatives and salts thereof, external skin preparations and cosmetics comprising specific α-branched acyl carnitine derivatives and/or salts thereof.

Claims (28)

1. An external skin preparation comprising a carnitine derivative represented by Formula (1) and/or a salt of carnitine derivative represented by Formula (2):

wherein one of R 1 and R 2 is a saturated aliphatic hydrocarbon group of 2 to 16 carbon atoms that may have a branch, and the other is a saturated aliphatic hydrocarbon group of 8 to 16 carbon atoms that may have a branch;

wherein R 1 and R 2 are as defined in Formula (1), X − is an inorganic or organic anion that maintains electrical neutrality with a cation part of the carnitine derivative, and Y + is an inorganic or organic cation that maintains electrical neutrality with an anion part of the carnitine derivative.

2. The external skin preparation according to claim 1 , wherein one of R 1 and R 2 in Formulae (1) and (2) is a linear alkyl group of 6 carbon atoms, and the other is a linear alkyl group of 8 carbon atoms.

3. The external skin preparation according to claim 1 , wherein X − in Formula (2) is an anion selected from the group consisting of hydroxide ion, nitrate ion, sulfate ion, carbonate ion, hydrogen carbonate ion, halide ion, formate ion, acetate ion, citrate ion, tartrate ion, oxalate ion, fumarate ion, saturated or unsaturated fatty acid anion of 3 to 20 carbon atoms that may have a branch, carnitine anion, carnitine derivative anion, ascorbate anion, ascorbylphosphate anion and ascorbylphosphate derivative anion.

4. The external skin preparation according to claim 1 , wherein Y + in Formula (2) is a cation selected from the group consisting of hydrogen ion, sodium ion, potassium ion, calcium ion, magnesium ion, zinc ion, ammonium ion, carnitine cation and carnitine derivative cation.

5. The external skin preparation according to claim 1 , wherein the carnitine derivative represented by Formula (1) and/or the salt of carnitine derivative represented by Formula (2) accounts for 0.01 to 20% by mass of the external skin preparation.

6. A cosmetic comprising 0.01 to 20% by mass of the carnitine derivative and/or the salt of carnitine derivative described in claim 1 .

7. The cosmetic according to claim 6 , which is a cosmetic for stimulating lipid metabolism.

8. A carnitine derivative represented by Formula (3):

wherein one of R 3 and R 4 is a saturated aliphatic hydrocarbon group of 1 to 16 carbon atoms that may have a branch, and the other is a saturated aliphatic hydrocarbon group of 8 to 16 carbon atoms that may have a branch.

9. A salt of carnitine derivative represented by Formula (4):

wherein one of R 3 and R 4 is a saturated aliphatic hydrocarbon group of 1 to 16 carbon atoms that may have a branch, the other is a saturated aliphatic hydrocarbon group of 8 to 16 carbon atoms that may have a branch, X − is an inorganic or organic anion that maintains electrical neutrality with a cation part of the carnitine derivative, and Y + is an inorganic or organic cation that maintains electrical neutrality with an anion part of the carnitine derivative.

10. A carnitine derivative represented by Formula (7):

11. A salt of carnitine derivative represented by Formula (8):

wherein X − is an inorganic or organic anion that maintains electrical neutrality with a cation part of the carnitine derivative, and Y + is an inorganic or organic cation that maintains electrical neutrality with an anion part of the carnitine derivative.

12. The salt of carnitine derivative according to claim 11 , wherein X − in Formula (8) is an anion selected from the group consisting of hydroxide ion, nitrate ion, sulfate ion, carbonate ion, hydrogen carbonate ion, halide ion, formate ion, acetate ion, citrate ion, tartrate ion, oxalate ion, fumarate ion, saturated or unsaturated fatty acid anion of 3 to 20 carbon atoms that may have a branch, carnitine anion, carnitine derivative anion, ascorbate anion, ascorbylphosphate anion and ascorbylphosphate derivative anion.

13. The salt of carnitine derivative according to claim 11 , wherein Y + in Formula (8) is a cation selected from the group consisting of hydrogen ion, sodium ion, potassium ion, calcium ion, magnesium ion, zinc ion, ammonium ion, carnitine cation and carnitine derivative cation.

14. A carnitine derivative represented by Formula (9):

15. A salt of carnitine derivative represented by Formula (10):

wherein X − is an inorganic or organic anion that maintains electrical neutrality with a cation part of the carnitine derivative, and Y + is an inorganic or organic cation that maintains electrical neutrality with an anion part of the carnitine derivative.

16. The salt of carnitine derivative according to claim 15 , wherein X − in Formula (10) is an anion selected from the group consisting of hydroxide ion, nitrate ion, sulfate ion, carbonate ion, hydrogen carbonate ion, halide ion, formate ion, acetate ion, citrate ion, tartrate ion, oxalate ion, fumarate ion, saturated or unsaturated fatty acid anion of 3 to 20 carbon atoms that may have a branch, carnitine anion, carnitine derivative anion, ascorbate anion, ascorbylphosphate anion and ascorbylphosphate derivative anion.

17. The salt of carnitine derivative according to claim 15 , wherein Y + in Formula (10) is a cation selected from the group consisting of hydrogen ion, sodium ion, potassium ion, calcium ion, magnesium ion, zinc ion, ammonium ion, carnitine cation and carnitine derivative cation.

18. A carnitine derivative represented by Formula (11):

19. A salt of carnitine derivative represented by Formula (12):

wherein X − is an inorganic or organic anion that maintains electrical neutrality with a cation part of the carnitine derivative, and Y + is an inorganic or organic cation that maintains electrical neutrality with an anion part of the carnitine derivative.

20. The salt of carnitine derivative according to claim 19 , wherein X − in Formula (12) is an anion selected from the group consisting of hydroxide ion, nitrate ion, sulfate ion, carbonate ion, hydrogen carbonate ion, halide ion, formate ion, acetate ion, citrate ion, tartrate ion, oxalate ion, fumarate ion, saturated or unsaturated fatty acid anion of 3 to 20 carbon atoms that may have a branch, carnitine anion, carnitine derivative anion, ascorbate anion, ascorbylphosphate anion and ascorbylphosphate derivative anion.

21. The salt of carnitine derivative according to claim 19 , wherein Y + in Formula (12) is a cation selected from the group consisting of hydrogen ion, sodium ion, potassium ion, calcium ion, magnesium ion, zinc ion, ammonium ion, carnitine cation and carnitine derivative cation.

Assignments (3)
CHANGE OF ADDRESS Recorded Feb 14, 2024
From: RESONAC CORPORATION
To: RESONAC CORPORATION
Reel/Frame 066599/0037 →
CHANGE OF NAME Recorded Jun 23, 2023
From: SHOWA DENKO K.K.
To: RESONAC CORPORATION
Reel/Frame 064082/0513 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2008
From: AOKI, HIROBUMI; KAMACHI, HARUMI; KURATA, YOHEI
To: SHOWA DENKO K.K.
Reel/Frame 020745/0538 →